Literature DB >> 11106891

Primary hyperparathyroidism detected in a health screening. The Trømsø study.

R Jorde1, K H Bønaa, J Sundsfjord.   

Abstract

Serum calcium was measured in 12,339 men and 13,394 women ages 25 to 75. Primary hyperparathyroidism, defined as a combination of serum calcium and parathyroid hormone (PTH) levels within the extreme or upper normal range, was diagnosed in 17 men and 47 women. The prevalence in both sexes increased with age. When 42 subjects with asymptomatic primary hyperparathyroidism were followed for 3 years, no significant increase in serum calcium or PTH was seen. In a subgroup of 473 men and 517 women ages 50 to 75, serum PTH was measured along with serum calcium. Depending on the criteria used to define primary hyperparathyroidism, the prevalence in older women within this subgroup ranged from 3.6% to 13.9%. The study concluded that a high prevalence of primary hyperparathyroidism exists in older women, although the progression of the disease, judging by serum calcium and PTH measurements, appears to be very slow.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106891     DOI: 10.1016/s0895-4356(00)00239-0

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  19 in total

1.  [Prophylactic parathyroidectomy for familial parathyroid carcinoma].

Authors:  O Gimm; K Lorenz; P Nguyen Thanh; U Schneyer; M Bloching; V M Howell; D J Marsh; B T Teh; U Krause; H Dralle
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 2.  Parathyroid hormone-dependent hypercalcemia.

Authors:  Judit Toke; Attila Patócs; Katalin Balogh; Péter Gergics; Balázs Stenczer; Károly Rácz; Miklós Tóth
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial.

Authors:  Anders Bergenfelz; Pia Lindblom; Sten Tibblin; Johan Westerdahl
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

4.  The relationship between blood pressure and serum parathyroid hormone with special reference to urinary calcium excretion: the Tromsø study.

Authors:  F Saleh; R Jorde; J Svartberg; J Sundsfjord
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

5.  Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.

Authors:  Helene Siilin; Ewa Lundgren; Hans Mallmin; Dan Mellström; Claes Ohlsson; Magnus Karlsson; Eric Orwoll; Osten Ljunggren
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

6.  [Multiple endocrine neoplasia type 1].

Authors:  V Gudziol; A Schulze; J Gastmeier; T Zahnert
Journal:  HNO       Date:  2007-11       Impact factor: 1.284

7.  Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010).

Authors:  Marcio L Griebeler; Ann E Kearns; Euijung Ryu; Matthew A Hathcock; L Joseph Melton; Robert A Wermers
Journal:  Bone       Date:  2014-12-11       Impact factor: 4.398

8.  Prevalence of hypercalcemia in hospitalised patients: effects of "correction" for serum albumin values.

Authors:  V Carnevale; M Pipino; M Antonacci; C Checchia; V D'Alessandro; M Errico; A Greco; A Varriale
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

9.  Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity.

Authors:  E Kamycheva; R Jorde; Y Figenschau; E Haug
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

10.  Effect on bone density of postoperative calcium and vitamin-D supplementation in patients with primary hyperparathyroidism: A retrospective study.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Bergenfelz
Journal:  Langenbecks Arch Surg       Date:  2008-06-11       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.